longboardpharma.com (LBPH) - Multiplikator Forward P/S
Longboard Pharmaceuticals complies with environmental regulations through laboratory safety and digital documentation. The organization's forward P/S, with a value fixed at , links market value to fundamentals. Longboard Pharmaceuticals possesses protected patents and liquid capital. The business's financial success relies on the commercial launch of innovative treatments for developmental delays and epilepsy.
Rincian metrik komprehensif lan analitis Longboard (LBPH)
- rega pasar lan target rega analis:
- indikator kapitalisasi pasar:
- statistik nilai buku emiten:
- indikator total utang lan likuiditas perusahaan:
Total Utang marang Modal Longboard Pharmaceuticals|LBPH - Koefisien utang jangka dawa marang modal|Utang jangka cendhak marang modal Longboard Pharmaceuticals|LBPH - Gunggung utang perusahaan|Rasio utang marang kapitalisasi buku Longboard|LBPH - Silihan lan utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Longboard Pharmaceuticals|Rasio cepet longboardpharma.com
- indikator pendapatan resik lan kelipatan nilai:
LBPH - Bathi resik|Proyeksi bathi mangsa ngarep Longboard Pharmaceuticals|LBPH - Koefisien rega marang bathi|Pangali Forward P/E Longboard Pharma|LBPH - Rega marang bathi kanthi panyesuaian wutah|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Longboard|LBPH - Bathi operasional EBITDA|Bathi resik saben saham sajrone 12 wulan pungkasan Longboard Pharmaceuticals|LBPH - Bathi saben saham sajrone patang kuartal pungkasan|Wutah bathi EPS kuartalan longboardpharma.com|LBPH - Prakiraan wutah bathi resik saben saham ing taun iki|Prakiraan wutah bathi kanggo taun ngarep Longboard Pharmaceuticals
- statistik dodolan lan pendapatan perusahaan:
Analisis fundamental perusahaan:LBPH (Longboard Pharmaceuticals, Inc.)
For Longboard Pharmaceuticals (LBPH), whose neurology operations are shielded from geopolitical risks by the US market, this indicator serves as a gauge of market optimism regarding future sales. By analyzing the forward price-to-sales ratio chart, an investor assesses the relationship between current market capitalization and projected revenue, where elevated values signal that the asset is overbought, while low values indicate an undervaluation of growth potential.
Pesaing wigati
Rasio rega marang prakiraan pendapatan Biogen BIIB|Rega forward marang dodolan NBIX|Regencell - Multiplikator Forward P/S|AXSM (Axsome Corp) - Kapitalisasi marang prakiraan pendapatan|ACAD (ACADIA Pharmaceuticals) - Multiplikator forward rega marang pendapatan|xenon-pharma.com - Rega forward marang dodolan|Rasio rega marang prakiraan pendapatan Viking Therapeutics, Inc.|Supernus Pharmaceuticals, Inc. - Rega mangsa ngarep marang pendapatan|Multiplikator Forward P/S CPRX|DNLI (Denali Corp) - Rega forward marang dodolan|Multiplikator Forward P/S HRMY (Harmony Biosciences)|Multiplikator Forward P/S biohavenpharma.com BHVN|AMLX - Rasio rega marang prakiraan pendapatan|Rega forward marang dodolan TRVI (Trevi Therapeutics Inc)|Praxis Medicines (PRAX) - Rasio rega marang prakiraan pendapatan|Multiplikator forward rega marang pendapatan Anavex Life Sciences Corp|CBLL (CeriBell, Inc.) - Multiplikator Forward P/S|Multiplikator Forward P/S Prothena Corporation|Multiplikator Forward P/S ALEC|Multiplikator forward rega marang pendapatan Annexon Biosciences ANNX|Multiplikator Forward P/S OMER (Omeros)|Neurogene Therapeutics (NGNE) - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|ACIU: Multiplikator forward rega marang pendapatan|VYGR - Multiplikator Forward P/S|NMRA (Neumora Therapeutics, Inc.) - Multiplikator forward rega marang pendapatan|SCLX: Rasio rega marang pendapatan sing dikarepake|TVGN (Tevogen Bio Holdings, Inc.) - Multiplikator Forward P/S|Alpha Cognition Corp (ACOG) - Rasio kapitalisasi marang dodolan sing dikarepake|Multiplikator Forward P/S CGTX|Multiplikator forward rega marang pendapatan inhibikase.com IKT|Multiplikator Forward P/S SAVA (Cassava Sciences)|Multiplikator Forward P/S Assertio Holdings ASRT|COYA - Rasio rega marang prakiraan pendapatan|VTGN: Rasio rega marang prakiraan pendapatan|ovidrx.com (OVID) - Rasio rega marang prakiraan pendapatan|ABOS - Rasio kapitalisasi marang dodolan sing dikarepake|Rasio rega marang prakiraan pendapatan CervoMed|Rasio rega marang prakiraan pendapatan ATHE|Multiplikator Forward P/S CLNN|Rasio rega marang prakiraan pendapatan PEPG (pepgen.com)|Rasio rega marang prakiraan pendapatan Jupiter Neurosciences Inc JUNS|RLMD (relmada.com) - Rega mangsa ngarep marang pendapatan|Annovis Bio - Multiplikator Forward P/S|Rega forward marang dodolan GRCE (Grace Therapeutics, Inc.)|Firefly Neuroscience Inc (AIFF) - Rasio rega marang prakiraan pendapatan|Kapitalisasi marang prakiraan pendapatan KLTO|NRSN (NeuroSense Therapeutics Ltd) - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep revivapharma.com RVPH|Multiplikator forward rega marang pendapatan MTVA (MetaVia Inc)|Multiplikator Forward P/S NeurAxis Inc. (NRXS)|Rasio rega marang prakiraan pendapatan Helius Medical Technologies HSDT|Rega forward marang dodolan PASG|NEUP - Rasio rega marang prakiraan pendapatan|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep minervaneurosciences.com|Athira Pharma (ATHA) - Rasio rega marang prakiraan pendapatan|ADXN (Addex Therapeutics Ltd.) - Rasio rega marang prakiraan pendapatan|Rasio rega marang prakiraan pendapatan Alzamend Neuro Inc.|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Cyclerion CYCN|Rasio rega marang prakiraan pendapatan Protagenic Therapeutics (PTIX)|pasitheaclinics.com - Kapitalisasi marang prakiraan pendapatan|Multiplikator Forward P/S CRGT (Cortigent)|Prakiraan rega marang pendapatan Avenue Therapeutics Inc.|Brainstorm Cell Therapeutics, Inc. - Multiplikator Forward P/S|CARA: Rasio rega marang prakiraan pendapatan|Chromocell Therapeutics (CHRO) - Rasio rega marang prakiraan pendapatan|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Eliem Therapeutics Inc. (ELYM)|ITCI (Intra-Cellular Therapies Inc.) - Multiplikator Forward P/S|Multiplikator Forward P/S Marinus Pharmaceuticals Inc|Rasio rega marang prakiraan pendapatan NKGen (NKGN)|NRBO (NeuroBo Pharma) - Rega forward marang dodolan|Multiplikator Forward P/S SAGE (Sage Therapeutics, Inc.)|SNPX: Kapitalisasi marang prakiraan pendapatan|TRVN: Multiplikator forward rega marang pendapatan|Rega forward marang dodolan VIGL (Vigil Neuroscience)|Anew Medical (WENA) - Rasio rega marang prakiraan pendapatan|Rega mangsa ngarep marang pendapatan CERE (Cerevel Corp)
